SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today that it will be participating in the Morgan Stanley Healthcare conference on Tuesday, September 9.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 11:10 a.m., Eastern Daylight Time (8:10 a.m., Pacific Daylight Time). The presentation will be available through the conference website at http://cc.talkpoint.com/morg007/090814a_ac/?entity=58_NUKKV3O and via the company’s website at www.volcanocorp.com.
About Volcano Corporation
Through its multi-modality platform, Volcano Corporation is the global leader in intravascular imaging for coronary and peripheral applications, and physiology. The company also offers a suite of peripheral therapeutic devices. The company’s broad range of technologies makes imaging and therapy simpler, more informative and less invasive and offers physicians and their patients around the world with industry-leading tools that aid diagnosis and guide and provide therapy. Founded in cardiovascular care and expanding into other specialties, Volcano is focused on improving patient and economic outcomes. For more information, visit the company’s website at www.volcanocorp.com.
SOURCE Volcano Corporation
Help employers find you! Check out all the jobs and post your resume.
